Tai Gan (泰苷)泰苷

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

腺嘌呤核苷是一种在国家药监局注册认定的药品。标注生产企业为陕西省科学院制药厂。

该药品暂无关联的活性成分信息。

该药品标注的生产企业为:陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂、陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂、陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 泰苷) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 陕西省科学院制药厂.

No active ingredient relationships are currently recorded for this product in MedicineGraph.

Manufacturers recorded for this product: 陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂, 陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂, 陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 泰苷Recorded Chinese name: 泰苷
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 20mg*36片/合Recorded Chinese specification: 20mg*36片/合

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

生产企业Manufacturer

  • 陕西省科学院制药厂Chinese legal name: 陕西省科学院制药厂

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H61023200

关联实体Relationships

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H61023200

Manufacturer

Chinese legal name: 陕西省科学院制药厂

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H61023200

生产企业

陕西省科学院制药厂

适应症

用于因辐射及放化疗或化疗引起的白细胞减少症和非特异性血小板减少症或白细胞减少症。用于急慢性肝炎、肝损伤及肝硬化的辅助治疗。

用法用量

口服,每日3次,每次2~3片,或遵医嘱。

不良反应

偶见腹痛、胃部不适等消化道刺激症状。
禁忌:对本品过敏者禁用。

禁忌

尚不明确。

注意事项

本品性状发生改变后禁止使用。

贮藏

避光密闭,干燥,阴凉处保存。

规格

20mg*36片/合

证据Evidence

  • 批准文号: 国药准字H61023200
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.